Health Note closes $17 million financing round

LabPulse.com staff writers
Jul 21, 2022
2022 07 22 18 26 0193 Doctor Fills Patient Medical Record 400

Health Note on Friday announced that it has closed a $17 million Series A financing round led by SignalFire, and joined by UnityPoint Health, Northwell Health Holdings, and Cedars Sinai Health Ventures.

The company has a preclinical intake automation platform that uses digital patient intake to prepare clinical notes for providers ahead of patient visits.

Health Note said it will use the funds to speed up market expansion, expand electronic health record (EHR) integrations, and invest in further research and development to build additional offerings for clinical support.

Latest in Research and Development
Pancreas New Social
Immunovia announces positive results for next-gen pancreatic cancer test
April 25, 2024
Visit our Molecular Diagnostics Community
Sponsored
Visit our Molecular Diagnostics Community
April 5, 2024
Business Graph Money Stocks
Fujifilm Diosynth Biotechnologies confirms layoffs
April 19, 2024
Quest Diagnostics Newsroom Media Gallery Photo Social
Quest and Broad partner for infant whole genome sequencing research
April 3, 2024
Related Stories
2022 01 26 23 43 5876 Niaid Sars Co V 2 Patient 400
RUO
Bruker launches long-COVID assessment test
2022 07 01 19 57 0654 Antibody Patch 400
Research and Development
Researchers eye blood-free COVID-19 antibody testing
2022 06 09 19 27 4366 Cell Gene Therapy Dna 400
Validation
Oxford BioDynamics launching oncology test in the U.K.
Visit our Molecular Diagnostics Community
Sponsor Content
Visit our Molecular Diagnostics Community
More in Research and Development
Immunovia announces positive results for next-gen pancreatic cancer test
By LabPulse.com staff writers
Diagnostics company Immunovia announced positive results for the newest generation of its pancreatic cancer test from a model-development study, announcing that the test achieved both its primary and secondary endpoints.
April 25, 2024
Pancreas New Social
Ipsen, Skyhawk to collaborate on drug discovery for rare neurological disorders
By LabPulse.com staff writers
Biopharmaceutical company Ipsen and clinical-stage biopharmaceutical firm Skyhawk have signed an exclusive collaboration to discover and develop small-molecule therapeutics targeting RNA to treat rare neurological disorders.
April 22, 2024
Nerve Neuron Axon Social
Fujifilm Diosynth Biotechnologies confirms layoffs
By LabPulse.com staff writers
Fujifilm Diosynth Biotechnologies confirmed a restructure that will result in the layoff of 240 employees.
April 19, 2024
Business Graph Money Stocks
Quest and Broad partner for infant whole genome sequencing research
By LabPulse.com staff writers
Quest Diagnostics and Broad Clinical Labs have announced a research collaboration exploring whole genome sequencing (WGS) on infants as a first-line genetic test for diagnosis of developmental delay disorders.
April 3, 2024
Quest Diagnostics Newsroom Media Gallery Photo Social
Castle Biosciences shares melanoma test study data at SSO 2024
By LabPulse.com staff writers
Castle Biosciences shared data from two studies on the performance of its DecisionDx-Melanoma test in patients with cutaneous melanoma at the Society of Surgical Oncology 2024 (SSO 2024) annual meeting, held March 20-23 in Atlanta.
March 26, 2024
Melanoma Social
ChromaCode partners with the Medical College of Georgia on NSCLC assay validation
By LabPulse.com staff writers
ChromaCode announced a partnership with the Medical College of Georgia to test the analytical and clinical performance of ChromaCode's HDPCR non-small cell lung cancer (NSCLC) biomarker assay.
March 21, 2024
Cancer Lung Social
International consortium launches project to develop next generation of vaccines
By Matt Limb
An international consortium of researchers specializing in human challenge studies is embarking on a $57 million project to develop advanced virus-blocking coronavirus vaccines.
March 15, 2024
Needle Syringe2 Social
Ginkgo Bioworks launches technology network
By Matt Limb
Ginkgo Bioworks has launched a new technology network with 25 partners, pledging to improve customers’ research and development outcomes.
March 6, 2024
Global Collaboration Business Social
New class of broad-spectrum antivirals could be first line of pandemic defense: Study
By Nick Paul Taylor
Targeting a cellular pathway has inhibited SARS-CoV-2 and other RNA viruses in preclinical tests, pointing to a potential new class of first-line antivirals with broad effectiveness against emerging pathogens.
March 5, 2024
Lab Virus Bacteria Research Social
AMDI receives $5.2M in RADx Tech funding for PCR viral testing system
By LabPulse.com staff writers
Autonomous Medical Devices Incorporated (AMDI) has received a U.S. National Institutes of Health (NIH) RADx Tech award of up to $5.2 million to finalize its rapid point-of-care viral testing system.
March 4, 2024
Money Bag Grant Award Social
Novartis presents first results of SMART spinal muscular atrophy study
By LabPulse.com staff writers
Company presents new data from a clinical study, called the SMART study, of its gene therapy in previously treated patients and a broader patient population.
March 5, 2024
Clinical Trial Data Network Social
BioMĂ©rieux, FDA to collaborate on combating food-borne pathogens
By LabPulse.com staff writers
BioMĂ©rieux has entered into a strategic research collaboration with the U.S. Food and Drug Administration (FDA) to develop technologies to improve the detection and characterization of food-borne pathogens.
March 1, 2024
Bacteria Microscope Social
Page 1 of 38
Next Page